Roche Files Third Suit This Month Over Boniva ANDAs
Friday, Hoffman-La Roche sued Apotex Inc. and Apotex Corp., citing an Abbreviated New Drug Application that sought a green light from the U.S. Food and Drug Administration to market 150 mg tablets of generic Boniva.
Hoffman-La Roche filed suit...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login